Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development

Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug development research 2004-06, Vol.62 (2), p.119-123
Hauptverfasser: Gunther, Erik C., Gerwien, Robert W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 2
container_start_page 119
container_title Drug development research
container_volume 62
creator Gunther, Erik C.
Gerwien, Robert W.
description Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ddr.10374
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17291280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17291280</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</originalsourceid><addsrcrecordid>eNp1kMtu1DAUQC0EEkNhwR94hcQi1HYejtlBh5ZWpaCKx9Jy7JvU4LFT25k2v8EXkyHAjtW9VzrnLg5Czyl5RQlhx8bEZSl59QBtKBFtwZgQD9GGMM6KqhT0MXqS0ndCKK3adoN-XkMKbso2eBx6rMG5yamIx5s52eDCMONuxgP4sLMaw_0YIaUDnOzgVZ4iYOWVW-D0Gr-N1gzWDzjfANbBZ_AZD2rEHeQ7AI-tx3ubY1gcsx77gE2cBmxgDy6Mu8V4ih71yiV49mceoS-n7z6fvC8uP56dn7y5LDQTTVW02oiW911HRF9SxbiqNeO0axqhO2iqGjrSKQKNIRXosq8FM7VipK16wbkuyyP0Yv07xnA7QcpyZ9MhgPIQpiQpZ4KylizgyxXUMaQUoZdjtDsVZ0mJPFSXS3X5u_rCHq_snXUw_x-U2-31X6NYDZsy3P8zVPwhG17yWn67OpMXn9rt1dcPp1KUvwA_kpcK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17291280</pqid></control><display><type>article</type><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Gunther, Erik C. ; Gerwien, Robert W.</creator><creatorcontrib>Gunther, Erik C. ; Gerwien, Robert W.</creatorcontrib><description>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 0272-4391</identifier><identifier>EISSN: 1098-2299</identifier><identifier>DOI: 10.1002/ddr.10374</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>cellular physiology ; genomic expression signature analysis ; in vitro and in vivo drug development</subject><ispartof>Drug development research, 2004-06, Vol.62 (2), p.119-123</ispartof><rights>2004 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fddr.10374$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fddr.10374$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids></links><search><creatorcontrib>Gunther, Erik C.</creatorcontrib><creatorcontrib>Gerwien, Robert W.</creatorcontrib><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><title>Drug development research</title><addtitle>Drug Dev. Res</addtitle><description>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</description><subject>cellular physiology</subject><subject>genomic expression signature analysis</subject><subject>in vitro and in vivo drug development</subject><issn>0272-4391</issn><issn>1098-2299</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp1kMtu1DAUQC0EEkNhwR94hcQi1HYejtlBh5ZWpaCKx9Jy7JvU4LFT25k2v8EXkyHAjtW9VzrnLg5Czyl5RQlhx8bEZSl59QBtKBFtwZgQD9GGMM6KqhT0MXqS0ndCKK3adoN-XkMKbso2eBx6rMG5yamIx5s52eDCMONuxgP4sLMaw_0YIaUDnOzgVZ4iYOWVW-D0Gr-N1gzWDzjfANbBZ_AZD2rEHeQ7AI-tx3ubY1gcsx77gE2cBmxgDy6Mu8V4ih71yiV49mceoS-n7z6fvC8uP56dn7y5LDQTTVW02oiW911HRF9SxbiqNeO0axqhO2iqGjrSKQKNIRXosq8FM7VipK16wbkuyyP0Yv07xnA7QcpyZ9MhgPIQpiQpZ4KylizgyxXUMaQUoZdjtDsVZ0mJPFSXS3X5u_rCHq_snXUw_x-U2-31X6NYDZsy3P8zVPwhG17yWn67OpMXn9rt1dcPp1KUvwA_kpcK</recordid><startdate>200406</startdate><enddate>200406</enddate><creator>Gunther, Erik C.</creator><creator>Gerwien, Robert W.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>200406</creationdate><title>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</title><author>Gunther, Erik C. ; Gerwien, Robert W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2964-8cd987fbb09f31a27a5c271b669cbe645eb0ba0e6d04ec3f592d5a2084f977c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>cellular physiology</topic><topic>genomic expression signature analysis</topic><topic>in vitro and in vivo drug development</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gunther, Erik C.</creatorcontrib><creatorcontrib>Gerwien, Robert W.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Drug development research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gunther, Erik C.</au><au>Gerwien, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development</atitle><jtitle>Drug development research</jtitle><addtitle>Drug Dev. Res</addtitle><date>2004-06</date><risdate>2004</risdate><volume>62</volume><issue>2</issue><spage>119</spage><epage>123</epage><pages>119-123</pages><issn>0272-4391</issn><eissn>1098-2299</eissn><abstract>Genomic expression profiling provides a high‐content means of characterizing the physiological action of drugs at the cellular systems biology level. By recognizing the distinct gene expression patterns that characterize various cellular states, it is possible to classify unknown drug treatments by the therapeutically relevant physiology they induce. Because the range of cellular physiologies is wide, and the resolution of expression profiling is comprehensive, this pattern recognition–based approach represents a generic means of drug action analysis and prediction. Drug candidate efficacy, specificity, and toxicity can be determined early in drug development, streamlining a process currently fraught with costly attrition and deficient in generating mechanistically new therapeutics. Drug Dev. Res. 62:119–123, 2004. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/ddr.10374</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-4391
ispartof Drug development research, 2004-06, Vol.62 (2), p.119-123
issn 0272-4391
1098-2299
language eng
recordid cdi_proquest_miscellaneous_17291280
source Wiley Online Library Journals Frontfile Complete
subjects cellular physiology
genomic expression signature analysis
in vitro and in vivo drug development
title Resolution of cellular physiology by genomic expression signature analysis: Bridging the content gap between in vitro and in vivo drug development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T04%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Resolution%20of%20cellular%20physiology%20by%20genomic%20expression%20signature%20analysis:%20Bridging%20the%20content%20gap%20between%20in%20vitro%20and%20in%20vivo%20drug%20development&rft.jtitle=Drug%20development%20research&rft.au=Gunther,%20Erik%20C.&rft.date=2004-06&rft.volume=62&rft.issue=2&rft.spage=119&rft.epage=123&rft.pages=119-123&rft.issn=0272-4391&rft.eissn=1098-2299&rft_id=info:doi/10.1002/ddr.10374&rft_dat=%3Cproquest_cross%3E17291280%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17291280&rft_id=info:pmid/&rfr_iscdi=true